Category: patients
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsTORISEL 25 MG/ML PERF FL + FL (Temsirolimus)
TORISEL 25 MG/ML PERF FL + FL (Temsirolimus) - Médicament désigné comme "orphelin" *First-line tr
View DetailsVENTAVIS 10 MCG/ML NEB A 1 ML (Iloprost)
VENTAVIS 10 MCG/ML NEB A 1 ML (Iloprost) - Maladie rare sans désignation orpheline Treatment of p
View DetailsVENTAVIS 10 MCG/ML NEB A 2 ML (Iloprost)
VENTAVIS 10 MCG/ML NEB A 2 ML (Iloprost) - Maladie rare sans désignation orpheline Treatment of p
View DetailsTHYROGEN 0,9 MG INJ FL (Thirotropine)
THYROGEN 0,9 MG INJ FL (Thirotropine) - Maladie rare sans désignation orpheline * For use with se
View DetailsVELCADE 1 MG INJ FL (Bortezomib)
VELCADE 1 MG INJ FL (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy or in
View DetailsVELCADE 3,5 MG INJ FL 1 (Bortezomib)
VELCADE 3,5 MG INJ FL 1 (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy o
View DetailsREPLAGAL 1 MG/ML FL 1 ML (Agalsidase Alfa)
REPLAGAL 1 MG/ML FL 1 ML (Agalsidase Alfa) - Maladie rare sans désignation orpheline Long-term en
View DetailsNOVOSEVEN 60K UI INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])
NOVOSEVEN 60K UI INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé]) - Malad
View DetailsNOVOSEVEN 8 MG (400K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])
NOVOSEVEN 8 MG (400K UI) INJ FL + FL (Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé])
View Details